David Ansell to Comorbidity
This is a "connection" page, showing publications David Ansell has written about Comorbidity.
Connection Strength
0.142
-
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Atherosclerosis. 2018 01; 268:99-107.
Score: 0.128
-
Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant. 2005 Dec; 20(12):2803-11.
Score: 0.014